// App-Quantinova.ai

4701 : Effectiveness and Cost of Rituximab for CLL in the Province of Manitoba Prior to Its Approval As Part of First Line Treatment

Researchers

Presenter

  • Rajat Kumar

Principal Investigators

  • James B Johnston

  • Joseph Baptiste

  • Bernie Lozar

  • Scott Streilein

  • Venetia Bourrier

  • Sri Navaratnam

Medical Centers

  • Provincial Oncology Drug Program, CancerCare Manitoba, Winnipeg, MB, Canada

  • Department of Medical Oncology/Hematology, CancerCare Manitoba, Winnipeg, MB, Canada

  • Information Services, CancerCare Manitoba, Winnipeg, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxyzine

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved